Embryonic stem cells as a model for cardiac development and disease

Drug Discovery Today: Disease Models

Volumn 5, Issue 3, 2008, Pages 147-155

  Evans, Todd ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; CARDIOVASCULAR AGENT;

AUTOTRANSPLANTATION; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL SURVIVAL; CELL TYPE; CLINICAL TRIAL; DISEASE MODEL; DRUG APPROVAL; DRUG EFFICACY; DRUG INDUSTRY; EMBRYONIC STEM CELL; ENDOTHELIUM; EXPLANT; GENE IDENTIFICATION; HEALING; HEART ARRHYTHMIA; HEART DEVELOPMENT; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; HUMAN; IN VITRO STUDY; LONG QT SYNDROME; MOLECULAR MODEL; NONHUMAN; PATHOGENESIS; PHARMACOGENETICS; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 67651238733     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2009.03.004     Document Type: Review

References (75)

1. Chico T.J., et al. Modeling cardiovascular disease in the zebrafish. Trends Cardiovasc. Med. 18 (2008) 150-155
2. McFadden D.G., and Olson E.N. Heart development: learning from mistakes. Curr. Opin. Genet. Dev. 12 (2002) 328-335
3. Warkman A.S., and Krieg P.A. Xenopus as a model system for vertebrate heart development. Semin. Cell Dev. Biol. 18 (2007) 46-53
4. Barile L., et al. Endogenous cardiac stem cells. Prog. Cardiovasc. Dis. 50 (2007) 31-48
5. Torella D., et al. Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration. Nat. Clin. Pract. Cardiovasc. Med. 3 Suppl. 1 (2006) S8-13
6. Keller G. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev. 19 (2005) 1129-1155
7. Murry C.E., and Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132 (2008) 661-680
8. Nussbaum J., et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J. 21 (2007) 1345-1357
9. Doetschman T.C., et al. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87 (1985) 27-45
10. Lacaud G., et al. Tracking mesoderm formation and specification to the hemangioblast in vitro. Trends Cardiovasc. Med. 14 (2004) 314-317
11. Fehling H.J., et al. Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development 130 (2003) 4217-4227
12. Kattman S.J., et al. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev. Cell 11 (2006) 723-732
13. Kattman S.J., et al. Specification of multipotential cardiovascular progenitor cells during embryonic stem cell differentiation and embryonic development. Trends Cardiovasc. Med. 17 (2007) 240-246
14. Laugwitz K.L., et al. Islet1 cardiovascular progenitors: a single source for heart lineages?. Development 135 (2008) 193-205
15. Moretti A., et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127 (2006) 1151-1165
16. Wu S.M., et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 127 (2006) 1137-1150
17. Christoforou N., et al. Mouse ES cell-derived cardiac precursor cells are multipotent and facilitate identification of novel cardiac genes. J. Clin. Invest. 118 (2008) 894-903
18. Olson E.N. Gene regulatory networks in the evolution and development of the heart. Science 313 (2006) 1922-1927
19. Holtzinger A., and Evans T. Gata5 and Gata6 are functionally redundant in zebrafish for specification of cardiomyocytes. Dev. Biol. 312 (2007) 613-622
20. Zhao R., et al. Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice. Dev. Biol. 317 (2008) 614-619
21. Zeineddine D., et al. Oct-3/4 dose dependently regulates specification of embryonic stem cells toward a cardiac lineage and early heart development. Dev. Cell 11 (2006) 535-546
22. Tzahor E. Wnt/beta-catenin signaling and cardiogenesis: timing does matter. Dev. Cell 13 (2007) 10-13
23. Foley A.C., et al. Embryonic heart induction. Ann. N. Y. Acad. Sci. 1080 (2006) 85-96
24. Naito A.T., et al. Developmental stage-specific biphasic roles of Wnt/beta-catenin signaling in cardiomyogenesis and hematopoiesis. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 19812-19817
25. Ueno S., et al. Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 9685-9690
26. Zaffran S., and Frasch M. Early signals in cardiac development. Circ. Res. 91 (2002) 457-469
27. Laflamme M.A., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25 (2007) 1015-1024
28. Yao S., et al. Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 6907-6912
29. Lough J., and Sugi Y. Endoderm and heart development. Dev. Dyn. 217 (2000) 327-342
30. Schultheiss T.M., et al. Induction of avian cardiac myogenesis by anterior endoderm. Development 121 (1995) 4203-4214
31. Rudy-Reil D., and Lough J. Avian precardiac endoderm/mesoderm induces cardiac myocyte differentiation in murine embryonic stem cells. Circ. Res. 94 (2004) e107-116
32. Liu Y., et al. Sox17 is essential for the specification of cardiac mesoderm in embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 3859-3864
33. Pal R., and Khanna A. Role of hepatocyte-like cells in the differentiation of cardiomyocytes from mouse embryonic stem cells. Stem Cells Dev. 14 (2005) 153-161
34. Klug M.G., et al. Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J. Clin. Invest. 98 (1996) 216-224
35. Cai J., et al. Transplantation of embryonic stem cell-derived cardiomyocytes improves cardiac function in infarcted rat hearts. Cytotherapy 9 (2007) 283-291
36. Leor J., et al. Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart 93 (2007) 1278-1284
37. Dimmeler S., et al. Cell-based therapy of myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 208-216
38. Passier R., et al. Stem-cell-based therapy and lessons from the heart. Nature 453 (2008) 322-329
39. Kolossov E., et al. Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J. Exp. Med. 203 (2006) 2315-2327
40. Roell W., et al. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 450 (2007) 819-824
41. Xu C., et al. Growth and differentiation of human embryonic stem cells for cardiac cell replacement therapy. Curr. Stem Cell Res. Ther. 1 (2006) 173-187
42. He J.Q., et al. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ. Res. 93 (2003) 32-39
43. Xu C., et al. Human embryonic stem cell-derived cardiomyocytes can be maintained in defined medium without serum. Stem Cells Dev. 15 (2006) 931-941
44. Mummery C., et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107 (2003) 2733-2740
45. Gallo P., et al. A lentiviral vector with a short troponin-I promoter for tracking cardiomyocyte differentiation of human embryonic stem cells. Gene Ther. 15 (2008) 161-170
46. Huber I., et al. Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB J. 21 (2007) 2551-2563
47. Xu X.Q., et al. Highly enriched cardiomyocytes from human embryonic stem cells. Cytotherapy 10 (2008) 376-389
48. Yang L., et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453 (2008) 524-528
49. Xu X.Q., et al. Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells. Differentiation 76 (2008) 958-970
50. Snir M., et al. Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H2355-2363
51. McDevitt T.C., et al. Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway. J. Mol. Cell Cardiol. 39 (2005) 865-873
52. 2+ handling and the role of sarcoplasmic reticulum in the contraction. Stem Cells 24 (2006) 236-245
53. Liu J., et al. Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation. Stem Cells 25 (2007) 3038-3044
54. Sartiani L., et al. Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach. Stem Cells 25 (2007) 1136-1144
55. Caspi O., et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J. Am. Coll. Cardiol. 50 (2007) 1884-1893
56. Dai W., et al. Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J. Mol. Cell Cardiol. 43 (2007) 504-516
57. van Laake L.W., et al. Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ. Res. 102 (2008) 1008-1010
58. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
59. Wernig M., et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448 (2007) 318-324
60. Okita K., et al. Generation of germline-competent induced pluripotent stem cells. Nature 448 (2007) 313-317
61. Maherali N., et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1 (2007) 55-70
62. Meissner A., et al. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol. 25 (2007) 1177-1181
63. Lowry W.E., et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 2883-2888
64. Park I.H., et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451 (2008) 141-146
65. Takahashi K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007) 861-872
66. Yu J., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318 (2007) 1917-1920
67. Mauritz C., et al. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118 (2008) 507-517
68. Narazaki G., et al. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 118 (2008) 498-506
69. Hanna J., et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318 (2007) 1920-1923
70. Rubin L.L. Stem cells and drug discovery: the beginning of a new era?. Cell 132 (2008) 549-552
71. Graichen R., et al. Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation 76 (2008) 357-370
72. Goldenberg I., and Moss A.J. Long QT syndrome. J. Am. Coll. Cardiol. 51 (2008) 2291-2300
73. Schwartz P.J. The congenital long QT syndromes from genotype to phenotype: clinical implications. J. Intern. Med. 259 (2006) 39-47
74. Caspi O., et al. In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes. Stem Cells Dev. 18 (2009) 161-172
75. Guan K., et al. Generation of functional cardiomyocytes from adult mouse spermatogonial stem cells. Circ. Res. 100 (2007) 1615-1625